Answers are grounded in this paper and cite their sources.
Demonstrates improved healing in meniscal tears using fibrin clot augmentation, suggesting practical benefits for patients.
Significant meniscal injuries lead to pain and possible early osteoarthritis development. Fibrin clot augmentation represents an effective, cost‐efficient method for improving healing rates in poorly vascularized meniscal tears. This arthroscopic technique shows fibrin clot augmentation combined with horizontal and vertical mattress sutures in a “ripstop” configuration for radial midbody medial meniscus tears. Thirty milliliters of autologous blood is collected and processed to form a fibrin clot, which is introduced inside‐out through an endotracheal tube to optimize surface contact within the tear. The clot is secured with braided sutures while meniscal repair is performed using 2‐0 polydioxanone sutures in a ripstop configuration. A similar technique may be used for any repair requiring biological augmentation. Rehabilitation protocols include 4 weeks of nonweight‐bearing, followed by graduated weight‐bearing to achieve full weight‐bearing by 8 weeks. Range‐of‐motion restrictions vary by tear location. This technique provides a cost‐effective, low‐complexity technique for biological augmentation of repair of high‐risk meniscus tears, potentially improving healing probability.
No takes yet. Share an insight, caveat, or question.
Padmanabhan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: